Akili, Inc. announced that it has entered subscription agreement for the private placement of 16,200,000 shares at a price of $10 per share for gross proceeds of $162,000,000 on January 26, 2022. The transaction will be led by Social Capital Suvretta Holdings Corp. I for $100,000,000 and include participation of $62,000,000 is committed by certain existing directors, officers and equity holders of investment funds managed by, SCS Sponsor I LLC, Suvretta Capital Management, LLC, new and existing investors including, Apeiron Investment Group Ltd., Temasek Holdings (Private) Limited, Eddie Martucci co-founder of PureTech Health, Evidity Health Capital, JAZZ Venture Partners and Omidyar Technology Ventures.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3925 USD | -1.88% | +60.20% | -19.42% |
Apr. 30 | Akili, Inc. Plans to Continue to Pursue Marketing Authorization from the U.S. Food and Drug Administration for Its EndeavorOTC Product | CI |
Apr. 30 | Akili, Inc. to Reduce Workforce | CI |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
219 GBX | +2.34% | +0.46% | 743M | ||
0.4016 USD | -1.76% | +63.92% | 182M | ||
1st Jan change | Capi. | |
---|---|---|
-19.42% | 31.56M | |
+7.84% | 218B | |
+7.35% | 184B | |
+13.04% | 135B | |
+26.03% | 107B | |
-1.33% | 62.38B | |
+11.80% | 51.37B | |
+4.81% | 50.9B | |
+0.30% | 40.87B | |
+2.78% | 36.28B |
- Stock Market
- Equities
- AKLI Stock
- News Akili, Inc.
- Akili, Inc. announced that it expects to receive $162 million in funding from a group of investors